UroToday

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases - Abstract

Published on Monday, 13 May 2013 09:25

Background: Substantial survival may be observed with oligometastatic prostate cancer.

Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer - Abstract

Published on Monday, 13 May 2013 09:16

Purpose: To determine if high-risk prostate cancer responds differently to hypofractionation.

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer - Abstract

Published on Monday, 13 May 2013 09:11

High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer.

A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy - Abstract

Published on Friday, 10 May 2013 15:11

BACKGROUND: The management of intermediate-risk prostate cancer (PCa) is controversial, in part due to the heterogeneous nature of patients falling within this classification.

Targeted MRI-guided prostate biopsies for the detection of prostate cancer: Initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion - Abstract

Published on Friday, 10 May 2013 15:04

OBJECTIVE: To prove the feasibility and evaluate the initial clinical results of targeted prostate biopsies using the Urostation novel platform using magnetic resonance imaging (MRI)/transrectal ultrasound (TRUS) registration to help steer the biopsy needle to suspicious areas.

Hypofractionated external-beam radiotherapy for prostate cancer - Abstract

Published on Friday, 10 May 2013 14:58

There are radiobiological rationales supporting hypofractionated radiotherapy for prostate cancer.

Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer - Abstract

Published on Friday, 10 May 2013 14:55

Weight loss or gain during the course of radiation therapy for prostate cancer can alter the planned dose to the target volumes and critical organs.

Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus - Abstract

Published on Friday, 10 May 2013 14:47

OBJECTIVE: To investigate the influence of diabetes mellitus (DM) on late genitourinary (GU) and gastrointestinal (GI) toxicity in patients treated with external beam radiotherapy (RT) for prostate cancer.

Traffic-related air pollution and prostate cancer risk: A case-control study in Montreal, Canada - Abstract

Published on Thursday, 09 May 2013 14:51

OBJECTIVES: There is a paucity of information on environmental risk factors for prostate cancer.

Hepatitis C transmission after prostate biopsy - Abstract

Published on Thursday, 09 May 2013 14:46

Prostate biopsy is a current and well-codified procedure; antibiotic prophylaxis and rectal enema limit the risk of infection.

Page 9 of 1746